• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情背景下国际虚拟培训在生物风险管理方面的效果。

Effectiveness of international virtual training on biorisk management in the context of COVID-19.

机构信息

Bahawalpur Medical and Dental College, Bahawalpur, Pakistan.

Global Health Security, Georgetown University, Washington, DC, United States.

出版信息

Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.

DOI:10.3389/fpubh.2022.888097
PMID:36339241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627603/
Abstract

INTRODUCTION

The COVID-19 pandemic has resulted in enormous increases in laboratory activities to keep pace with diagnostic testing and research efforts. However, traditional training, technical assistance, and capacity-building approaches were disrupted by the travel and movement restrictions put in place to control the spread of the disease. To address the needs of laboratorians and managers to conduct laboratory activities safely and securely during the pandemic, a highly interactive virtual training (IVT) workshop on biorisk management during COVID-19 was conducted through active learning strategies that connected speakers with participants. The objective of the training was to increase the basic knowledge and standards of biosafety and biosecurity practices, risk assessment, and control measures with reference specifically to the context of the COVID-19 pandemic and apply a rigorous evaluation methodology to assess the effectiveness of the IVT. The training covered a broad range of topics and encompassed national to international guidelines.

METHODS

Participants were selected through official channels at the national level, focusing on institutions within Pakistan. The sessions included lectures from international experts in biorisk management concepts, and incorporated poll questions as well as pre- and post-tests and feedback on the speakers' knowledge and presentation skills, to increase interactivity. The pre- and post-test comprised similar multiple-choice questions and provided to every participant to ascertain the impact of the training on awareness and knowledge of biorisk management topics and concepts, and results were compared using paired -tests. For feedback on the speakers, participants were asked to submit their ratings measured on a five-point Likert scale. The reliability of the Likert scale was estimated using Cronbach's alpha. Analyses were performed using Microsoft Excel and SPSS version 23.

RESULTS

In total, 52 individuals from different laboratories across Pakistan and Pakistani students from abroad (China) as well participated in at least one session of the IVT. The participants' pre- and post-test scores showed a significant increase in knowledge and awareness ( < 0.001). The obtained Cronbach's alpha score was >0.8, indicating high reliability of the generated feedback on the IVT approach and speakers.

CONCLUSION

The IVT on biosafety and biosecurity in the context of the COVID-19 pandemic proved beneficial for laboratory professionals and could be a useful model to continue in the future for raising awareness and knowledge.

摘要

简介

COVID-19 大流行导致实验室活动大幅增加,以跟上诊断检测和研究工作的步伐。然而,由于为控制疾病传播而采取的旅行和流动限制,传统的培训、技术援助和能力建设方法受到了干扰。为了满足实验室人员和管理人员在大流行期间安全、有保障地开展实验室活动的需求,通过积极学习策略,举办了一场关于 COVID-19 期间生物风险管理的高度互动虚拟培训 (IVT) 研讨会,将演讲者与参与者联系起来。培训的目的是提高生物安全和生物安保实践、风险评估和控制措施的基本知识和标准,特别是参考 COVID-19 大流行的背景,并应用严格的评估方法来评估 IVT 的效果。培训涵盖了广泛的主题,包括国家和国际准则。

方法

通过国家一级的官方渠道选择参与者,重点是巴基斯坦境内的机构。课程包括国际生物风险管理专家的讲座,并纳入民意测验问题以及培训前后测试,以评估演讲者的知识和演示技能,从而提高互动性。培训前后测试由类似的多项选择题组成,并提供给每位参与者,以确定培训对生物风险管理主题和概念的意识和知识的影响,并使用配对检验进行比较。为了评估演讲者,要求参与者在五点李克特量表上提交他们的评分。使用 Cronbach 的 alpha 估计李克特量表的可靠性。使用 Microsoft Excel 和 SPSS 版本 23 进行分析。

结果

总共有来自巴基斯坦不同实验室的 52 人和在国外(中国)的巴基斯坦学生参加了至少一次 IVT。参与者的培训前后测试分数显示出知识和意识的显著提高(<0.001)。获得的 Cronbach 的 alpha 分数>0.8,表明对 IVT 方法和演讲者的反馈具有高度可靠性。

结论

在 COVID-19 大流行背景下的生物安全和生物安保 IVT 对实验室专业人员是有益的,并且可以成为未来提高意识和知识的有用模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/9627603/0946e2691ca1/fpubh-10-888097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/9627603/0946e2691ca1/fpubh-10-888097-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/9627603/0946e2691ca1/fpubh-10-888097-g0001.jpg

相似文献

1
Effectiveness of international virtual training on biorisk management in the context of COVID-19.新冠疫情背景下国际虚拟培训在生物风险管理方面的效果。
Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.
2
A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省研究和诊断实验室生物风险管理系统的横断面调查。
Front Public Health. 2021 Dec 17;9:766162. doi: 10.3389/fpubh.2021.766162. eCollection 2021.
3
A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.为巴基斯坦实验室编写生物风险手册的指导计划。
Appl Biosaf. 2022 Dec 1;27(4):219-224. doi: 10.1089/apb.2022.0007. Epub 2022 Nov 23.
4
Implementing an Organizational Culture of Biosafety and Biosecurity in the ŞAP Institute.在ŞAP研究所实施生物安全和生物安保的组织文化。
Health Secur. 2024 Aug;22(4):271-280. doi: 10.1089/hs.2023.0044. Epub 2024 May 30.
5
Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.加强布基纳法索的生物风险管控能力:全球卫生安全议程的贡献
Health Secur. 2022 Nov-Dec;20(6):479-487. doi: 10.1089/hs.2019.0069. Epub 2022 Nov 18.
6
Biosafety and biosecurity measures: management of biosafety level 3 facilities.生物安全和生物安保措施:三级生物安全设施的管理。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S70-4. doi: 10.1016/j.ijantimicag.2010.06.026. Epub 2010 Aug 30.
7
[Biorisk Management for Clinical Diagnostic Laboratories].临床诊断实验室的生物风险管控
Rinsho Byori. 2016 Nov;64(11):1279-1289.
8
Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.生物安全三级实验室中 SARS-CoV-2 研究的生物风险管理。
Methods Mol Biol. 2022;2452:441-464. doi: 10.1007/978-1-0716-2111-0_24.
9
Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic.新冠疫情期间巴基斯坦临床诊断实验室生物安全实施情况评估
J Biosaf Biosecur. 2022 Jun;4(1):43-49. doi: 10.1016/j.jobb.2022.01.001. Epub 2022 Jan 19.
10
Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.提供冠状病毒 SARS-CoV-2/(COVID-19)诊断的实验室的基础设施生物风险评估和生物安全要求。
Indian J Med Res. 2020;151(2 & 3):172-176. doi: 10.4103/ijmr.IJMR_763_20.

引用本文的文献

1
Analysis of compliance issues and influencing factors in the management of BSL-2 laboratories for pathogenic microorganisms in Lishui, China.中国丽水致病性微生物BSL-2实验室管理中的合规问题及影响因素分析
Front Bioeng Biotechnol. 2025 Aug 8;13:1637056. doi: 10.3389/fbioe.2025.1637056. eCollection 2025.

本文引用的文献

1
Biosafety Capacity Building During the COVID-19 Pandemic: Results, Insights, and Lessons Learned from an Online Approach in the Philippines.新冠疫情期间的生物安全能力建设:菲律宾线上模式的成果、见解与经验教训
Appl Biosaf. 2022 Mar 1;27(1):42-50. doi: 10.1089/apb.2021.0021. Epub 2022 Mar 15.
2
Materials in advanced design of personal protective equipment: a review.个人防护装备的先进设计材料:综述
Mater Today Adv. 2021 Dec;12:100171. doi: 10.1016/j.mtadv.2021.100171. Epub 2021 Sep 8.
3
National Biosafety Management System: A Combined Framework Approach Based on 15 Key Elements.
国家生物安全管理体系:基于 15 个关键要素的综合框架方法。
Front Public Health. 2021 Jul 23;9:609107. doi: 10.3389/fpubh.2021.609107. eCollection 2021.
4
Analysis of Bio-Risk Management System Implementation in Indonesian Higher Education Laboratory.印度尼西亚高等教育实验室生物风险管理系统实施分析。
Int J Environ Res Public Health. 2021 May 11;18(10):5076. doi: 10.3390/ijerph18105076.
5
Implementation of Bio-Risk Management System in a National Clinical and Medical Referral Centre Laboratories.国家临床与医学转诊中心实验室的生物风险管理制度的实施。
Int J Environ Res Public Health. 2021 Feb 26;18(5):2308. doi: 10.3390/ijerph18052308.
6
Challenges and Controversies to Testing for COVID-19.新冠病毒检测面临的挑战和争议。
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01695-20.
7
Impact of COVID-19 on laboratory professionals-A descriptive cross sectional survey at a clinical chemistry laboratory in a developing country.新型冠状病毒肺炎对实验室专业人员的影响——在某发展中国家一家临床化学实验室开展的描述性横断面调查
Ann Med Surg (Lond). 2020 Jul 18;57:70-75. doi: 10.1016/j.amsu.2020.07.022. eCollection 2020 Sep.
8
Laboratory biosafety for handling emerging viruses.处理新出现病毒的实验室生物安全。
Asian Pac J Trop Biomed. 2017 May;7(5):483-491. doi: 10.1016/j.apjtb.2017.01.020. Epub 2017 Jan 7.
9
Public awareness, acceptability and risk perception about infectious diseases dual-use research of concern: a cross-sectional survey.公众对关注的传染病双重用途研究的认识、可接受性和风险感知:一项横断面调查。
BMJ Open. 2020 Jan 6;10(1):e029134. doi: 10.1136/bmjopen-2019-029134.
10
Survey of Suspected Laboratory-Acquired Infections and Biosafety Practices in Research, Clinical, and Veterinary Laboratories in Karachi, Pakistan.巴基斯坦卡拉奇研究、临床和兽医实验室疑似实验室获得性感染和生物安全实践调查。
Health Secur. 2019 Sep/Oct;17(5):372-383. doi: 10.1089/hs.2019.0057.